| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Ahmed R | |
| Murali-Krishna K | |||
| Zajac AJ | |||
| Blattman JN | |||
| P2860 | cites work | Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. | Q52040367 |
| Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells | Q56338635 | ||
| An Essential Role for Type 1 Interferon-γ in Terminating Persistent Viral Infection | Q58828960 | ||
| Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones | Q67518698 | ||
| Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression | Q71803154 | ||
| CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones | Q28209894 | ||
| Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice | Q28594763 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Principles for adoptive T cell therapy of human viral diseases | Q34300059 | ||
| Immune function in mice lacking the perforin gene | Q35882128 | ||
| Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. | Q35887911 | ||
| Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity | Q36366051 | ||
| Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells | Q36367286 | ||
| Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. | Q36400784 | ||
| Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. | Q36623371 | ||
| CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection | Q36637922 | ||
| Immune therapy of a persistent and disseminated viral infection. | Q36920380 | ||
| Massive expansion of antigen-specific CD8+ T cells during an acute virus infection | Q37419599 | ||
| Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure | Q37595741 | ||
| Generation, translocation, and presentation of MHC class I-restricted peptides | Q40422033 | ||
| Hepatitis B virus immunopathogenesis | Q40444875 | ||
| Large clonal expansions of CD8+ T cells in acute infectious mononucleosis | Q40665903 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo | Q41039693 | ||
| To kill or to cure: options in host defense against viral infection. | Q41103038 | ||
| The cell-mediated immune response against lymphocytic choriomeningitis virus in beta 2-microglobulin deficient mice | Q41126124 | ||
| Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. | Q41365854 | ||
| Functions of CD8 T-cell subsets secreting different cytokine patterns. | Q41508127 | ||
| Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 | Q41589138 | ||
| Viral strategies of immune evasion | Q41735903 | ||
| Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo | Q41764334 | ||
| A new look at T cells | Q41896404 | ||
| Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells | Q42977014 | ||
| Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells | Q44615042 | ||
| Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells | Q45151385 | ||
| Virus-specific CD8+ T cells in primary and secondary influenza pneumonia | Q45755057 | ||
| Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes | Q45771097 | ||
| Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes | Q45771892 | ||
| Immune exhaustion: driving virus-specific CD8+ T cells to death | Q45779190 | ||
| T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions | Q47982736 | ||
| Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
| A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
| P433 | issue | 4 | |
| P921 | main subject | cooperation | Q380962 |
| P304 | page(s) | 444-449 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells | |
| P478 | volume | 10 |
| Q36958112 | A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. |
| Q36189261 | A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions |
| Q40896159 | A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes |
| Q34842204 | All in the head: obstacles for immune rejection of brain tumours |
| Q48152277 | Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. |
| Q36643661 | Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer. |
| Q37460652 | CD4(+) T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs |
| Q35219026 | Cancer vaccines: between the idea and the reality |
| Q44996566 | Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine |
| Q34342413 | Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization |
| Q39169715 | Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines |
| Q42642562 | Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help |
| Q33811983 | Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice. |
| Q44946314 | Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B. |
| Q44448449 | Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins |
| Q74080209 | Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen |
| Q35826514 | Genetic modification of T lymphocytes for adoptive immunotherapy |
| Q33574329 | Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful |
| Q35731386 | Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. |
| Q37406571 | Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques |
| Q37620833 | Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. |
| Q33905225 | Immunological memory and acquired immunodeficiency syndrome pathogenesis |
| Q51019176 | Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. |
| Q43276074 | Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. |
| Q36358909 | Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors |
| Q34856857 | Induction and function of virus-specific CD4+ T cell responses |
| Q40855997 | Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response. |
| Q42233712 | Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells |
| Q33287802 | Interleukin-10 plays an early role in generating virus-specific T cell anergy |
| Q40628602 | Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity |
| Q37118150 | Multiple roles for CD4+ T cells in anti-tumor immune responses |
| Q34913212 | Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection |
| Q33847673 | Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment |
| Q34466498 | Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options |
| Q81690451 | Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland |
| Q62129133 | Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques |
| Q33977826 | Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses |
| Q34981964 | T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus |
| Q35073666 | T helper lymphocytes rescue CTL from activation-induced cell death |
| Q34228659 | Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection |
| Q42255546 | The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study |
| Q33748013 | The makings of a tumor rejection antigen |
| Q80038678 | The promise of cancer vaccines |
| Q34232543 | The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity |
| Q45429014 | Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model |
| Q41316816 | Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma |
| Q35150143 | Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene |
| Q36900143 | Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments |
Search more.